SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : The New Qualcomm - write what you like thread.
QCOM 170.90-1.3%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Maurice Winn who wrote (1865)7/14/2000 7:29:45 PM
From: quidditch  Read Replies (2) of 12231
 
Mq, thank you. I think it takes adversity, or at least close proximity to Q's traditional home in the 40's (I don't know, yet, what G*'s traditional home is--I guess it's been in the digital (as in doigts and integers)range rather than the buy range), to get your juices flowing, to wit:

Message 14050113

Actuall, the advent of the canary would signal a massive short cover day, so maybe you should coordinate the massive Labor Day Short Massacre with the yellow one, who should be back any day from the Tour. There are memorable days in August, but they are too terrible to contemplate, even for the shorts.

Or, to wit:

The definition of vaporware absolutely applies to W-CDMA. In fact it still remains in the VapourWear category, which old-time readers will recognize as a different kettle of fish.

You're perhaps correct that it's too circuitous a journey to bring solar to hydrogen, but ENER does indeed have a way of storing hydrogen in solid state, which could be a boon. The President of one of the competitors to your former stomping grounds says so.

By the way, did all of you here happen to notice that CSFB sued several members of a Yahoo thread whom CSFB accused of defaming one of its analysts--David Maris (held in regard to some stocks as Snyder is to the Q). I know Maurice would be interested in this little interplay between IT and the old guard because of the reportage of your fling with the WSJ.

By the way, 2, Maris also happened to have it in for SEPR, which is a good but expensive young pharmaceutical firm: it has many drugs in the pipeline for addressing allergies and asthmas (including one FDA approved xopenex which is an improvement over albuterol). But as for Ig-E, oral is king, because most of us don't like stings.

Steve
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext